Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 07/06/20181 min de leitura
Advisory Committee; Pulmonary-Allergy Drugs Advisory Committee, Renewal
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the renewal of the Pulmonary-Allergy Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Pulmonary- Allergy Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until May 30, 2020.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →